Role of Prophylactic Aggressive Hydration to Prevent Post-ERCP Pancreatitis
NCT07417020 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126
Last updated 2026-02-18
Summary
Endoscopic Retrograde Cholangiopancreatography, also called ERCP, is a procedure used to diagnose and treat disorders of the bile ducts and pancreas. A common and potentially serious complication after ERCP is post ERCP pancreatitis, which is inflammation of the pancreas that can cause abdominal pain, raised pancreatic enzymes, prolonged hospital stay, and increased health care costs. Several preventive approaches have been evaluated, but an optimal, simple strategy that can be applied consistently in routine practice remains uncertain. This randomized controlled trial was evaluated whether giving a higher amount of intravenous lactated Ringer's solution around the time of ERCP reduces the risk of post ERCP pancreatitis compared with standard hydration. Adults aged 18 to 70 years undergoing their first ERCP for choledocholithiasis, bile duct leak, or biliary obstruction were randomly allocated to standard hydration or aggressive hydration. Standard hydration consists of lactated Ringer's solution at 1.5 mL/kg/hour during ERCP and for 8 hours after the procedure. Aggressive hydration consisted of lactated Ringer's solution at 3 mL/kg/hour during ERCP, followed immediately by a 20 mL/kg bolus and then 3 mL/kg/hour for 8 hours, with reduction to 1.5 mL/kg/hour if pain is absent after 8 hours. The primary hypothesis was that aggressive hydration is more effective than standard hydration in preventing post ERCP pancreatitis. Post procedure serum amylase was measured at 12 and 24 hours, and pain was assessed using a visual analog scale at 4, 12, and 24 hours. The main outcome is post ERCP pancreatitis, defined by new or worsening abdominal pain with enzyme elevation more than three times the upper limit of normal at 24 hours and a hospital stay of at least 2 days. Secondary outcomes include isolated hyperamylasemia, post procedure pain, and length of hospital stay. The study was conducted over 12 months at the Department of Gastroenterology, Lahore General Hospital, Lahore, with a total sample size of 126 participants.
Conditions
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Choledocholithiasis
- Bile Duct Disorder
- Biliary Obstruction
Interventions
- OTHER
-
Aggressive intravenous hydration with lactated Ringer's solution
Lactated Ringer's solution at 3 mL/kg/hour during endoscopic retrograde cholangiopancreatography. Immediately after the procedure, 20 mL/kg bolus of lactated Ringer's solution. Then 3 mL/kg/hour for 8 hours. If no pain after 8 hours, rate reduced to 1.5 mL/kg/hour. Hydration discontinued once the patient can comfortably tolerate a regular diet
- OTHER
-
Standard intravenous hydration with lactated Ringer's solution
Lactated Ringer's solution at 1.5 mL/kg/hour during endoscopic retrograde cholangiopancreatography. Continued at 1.5 mL/kg/hour for 8 hours after the procedure. If post endoscopic retrograde cholangiopancreatography pancreatitis develops, a 20 mL/kg bolus may be administered, followed by 3 mL/kg/hour, as per management protocol
Sponsors & Collaborators
-
Lahore General Hospital
lead OTHER_GOV
Principal Investigators
-
Ali Hassan · Lahore General Hospital, Lahore
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-02
- Primary Completion
- 2025-03-01
- Completion
- 2025-03-01
Countries
- Pakistan
Study Locations
More Related Trials
-
Early Oral Carbohydrate Solution vs Clear Liquid Diet in Acute Pancreatitis
NCT07375186 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Outcome of Carbon Dioxide Versus Air Insufflations During Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01321203 ·Status: COMPLETED
-
Prevention of Desaturations Using Positive Airway Pressure or Capnometry During ERCP
NCT07056075 ·Status: RECRUITING ·Phase: NA
-
Patient Positioning and Airway Management During ERCP
NCT02850887 ·Status: COMPLETED ·Phase: NA
-
Effect of Deep Analgosedation vs. Endotracheal Intubation General Anesthesia on on Perioperative Sedation Related Adverse Events in Elderly ERCP Patients
NCT07017283 ·Status: RECRUITING ·Phase: NA
-
Hemodynamic Monitoring in Hepatopancreaticobiliary (HPB) Surgery
NCT03612687 ·Status: COMPLETED
-
Microaspiration in ERCP
NCT04831489 ·Status: UNKNOWN
-
Enhanced Recovery After Cardiac Surgery
NCT03859102 ·Status: UNKNOWN ·Phase: NA
-
Capnography During ERCP
NCT01072474 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of IV Lidocaine on Duodenal Peristalsis and Sedation in ERCP
NCT07333859 ·Status: COMPLETED ·Phase: PHASE4
-
Box Breathing for Anxiety, Pain and Nausea in ERCP Patients
NCT07328477 ·Status: COMPLETED ·Phase: NA
-
COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients
NCT07012772 ·Status: RECRUITING ·Phase: PHASE2
-
High Flow Nasal Cannula in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) HF-study
NCT04082208 ·Status: UNKNOWN ·Phase: NA
-
Dexmedetomidine Versus Placebo in Endoscopic Retrograde Cholangiopancreatography (ERCP) Sedation
NCT01070680 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis
NCT06861010 ·Status: RECRUITING ·Phase: PHASE3
-
Pharmacological Prophylaxis of Post- Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
NCT03708458 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Serial Magnetic Resonance Cholangiopancreatography (MRCP) Following Morphine-neostigmine and Secretin Provocation in Healthy Volunteers
NCT01134848 ·Status: COMPLETED ·Phase: PHASE4
-
Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)
NCT02111707 ·Status: COMPLETED ·Phase: PHASE4
-
HFNO Versus Nasal CPAP in Obese Patients Undergoing Deep Sedation for ERCP
NCT04912102 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
High Flow Nasal Cannula in Patients Undergoing ERCP Retrograde Cholangiopancreatography With Intravenous Sedation.
NCT04184089 ·Status: COMPLETED ·Phase: NA
-
EEG-Guided Sedation in ERCP Procedures
NCT06866886 ·Status: COMPLETED
-
Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis
NCT04997967 ·Status: UNKNOWN ·Phase: PHASE4
-
Cocktail Sedation Containing Propofol Versus Conventional Sedation for Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT01540084 ·Status: COMPLETED ·Phase: PHASE4
-
CO2 Versus O2 Insufflation During ERCP Depending on Sedation Protocols
NCT01761474 ·Status: COMPLETED
-
Does Capnography Prevent Hypoxemia During Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound?
NCT00675415 ·Status: COMPLETED ·Phase: NA